Resources
Filter by Topic
- Blogs
By Samy Suissa, PhD, Distinguished James McGill Professor of Epidemiology, Biostatistics, and Medicine, McGill University
- Press Releases
Panalgo, a Norstella company dedicated to revolutionizing healthcare data analytics, is announcing a new venture with partner OM1, a forefront leader in real-world evidence (RWE)...
- Press Releases
Norstella, one of the largest global pharma intelligence solution providers, today announced a strategic partnership with Atropos Health, the pioneer in translating real-world clinical data...
- Blogs
By Peter Neumann Director, Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center;...
- Blogs
By Meg Richards, PhD, MPH, Executive Director of Solutions, Panalgo
- Articles
By Meg Richards, PhD, MPH, Executive Director, Scientific Strategy at Panalgo, with Andrew Goldstein, VP of Client Partnerships at Panalgo
- Blogs
Three Key Themes from Panalgo’s Data to Insights 2024 Conference
MMIT/Evaluate Acquire Panalgo to Bring Speed and Trust to Pharma Analytics and Decision-Making
September 28, 2021, Yardley, PA – Managed Markets Insight & Technology (MMIT) and Evaluate (a Welsh, Carson, Anderson & Stowe and Hg portfolio company)—which joined
RWE: Supporting Regulatory Submissions with Real-World Evidence
In this article with HIT Consultant, Tiffany Siu Woodworth, Director of Analytics Solutions at Panalgo, discusses RWE within the regulatory landscape. She notes how in
The IMPact of untReated nOn-Valvular atrial fibrillation on short-tErm clinical and economic outcomes in the US Medicare population: the IMPROVE-AF model
Click here for the publication.
Podium and Posters from ICPE 2021
PODIUM PRESENTATION: Predictors of Severe COVID-19 Outcomes in Patients with Rheumatoid Arthritis Presented by Sara Burns SPOTLIGHT POSTER: Factors Associated with Initiation of Oral vs.
Leveraging RWD in Observational Studies: Understanding the Implications of Time-Related Biases
Dr. Suissa spoke at Panalgo’s 2021 IHD User conference about the implications of relying on observational studies that may have time-related biases and how to
Innovating RWE Organizations: Learning from the Past and Looking to the Future
Chris spoke at Panalgo’s 2021 IHD User conference about the evolution of Real-World Evidence (RWE) and how pharma needs to reimagine its function – to
IHD Analytics
Put reliable, rapid analytics in the hands of more people across your organization